This content is only available within our institutional offering.

23 Feb 2023
Hikma Pharmaceuticals (HIK.L, 2150p, Buy) (Results Review) - FY22: 2-3% Beat; FY23E guidance: no material changes

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals (HIK.L, 2150p, Buy) (Results Review) - FY22: 2-3% Beat; FY23E guidance: no material changes
Hikma Pharmaceuticals Plc (HIK:LON) | 1,786 -536 (-1.7%) | Mkt Cap: 3,964m
- Published:
23 Feb 2023 -
Author:
Miles Dixon | Edward Sham -
Pages:
8 -